19.76
price up icon1.49%   0.29
after-market After Hours: 19.76
loading
Tectonic Therapeutic Inc stock is traded at $19.76, with a volume of 132.12K. It is up +1.49% in the last 24 hours and up +4.77% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$19.47
Open:
$19.46
24h Volume:
132.12K
Relative Volume:
0.27
Market Cap:
$369.83M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.80%
1M Performance:
+4.77%
6M Performance:
-11.94%
1Y Performance:
-57.38%
1-Day Range:
Value
$19.07
$19.91
1-Week Range:
Value
$19.07
$21.00
52-Week Range:
Value
$13.70
$61.07

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name
Name
Tectonic Therapeutic Inc
Name
Phone
(339) 666-3320
Name
Address
490 ARSENAL WAY, WATERTOWN
Name
Employee
51
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
TECX's Discussions on Twitter

Compare TECX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TECX
Tectonic Therapeutic Inc
19.76 364.41M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-20-25 Initiated Wells Fargo Overweight
Sep-03-25 Initiated Oppenheimer Outperform
Jul-21-25 Initiated Truist Buy
Jun-11-25 Resumed Raymond James Outperform
Apr-21-25 Initiated Mizuho Outperform
Nov-20-24 Initiated Raymond James Outperform
Aug-22-24 Initiated Wells Fargo Overweight
Jun-26-24 Initiated Piper Sandler Overweight
Jun-24-24 Initiated TD Cowen Buy
Dec-18-23 Downgrade Mizuho Buy → Neutral
Jan-05-22 Downgrade BTIG Research Buy → Neutral
Nov-19-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-15-21 Initiated BTIG Research Buy
May-27-21 Initiated Needham Buy
Mar-09-21 Initiated Barclays Overweight
Mar-02-21 Initiated Stifel Hold
Nov-11-20 Initiated Berenberg Buy
Mar-31-20 Downgrade H.C. Wainwright Buy → Neutral
Jun-27-19 Initiated Mizuho Buy
Apr-05-19 Initiated Janney Buy
Oct-10-18 Initiated Guggenheim Buy
Oct-02-18 Reiterated H.C. Wainwright Buy
Sep-17-18 Initiated H.C. Wainwright Buy
Jul-16-18 Initiated Wedbush Outperform
Jul-16-18 Initiated Wells Fargo Outperform
View All

Tectonic Therapeutic Inc Stock (TECX) Latest News

pulisher
Dec 12, 2025

Tectonic Therapeutic (TECX): LifeSci Capital reiterates buy rating - MSN

Dec 12, 2025
pulisher
Dec 10, 2025

Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating - Finviz

Dec 10, 2025
pulisher
Dec 05, 2025

Will Tectonic Therapeutic Inc. stock continue upward momentumProfit Target & Community Consensus Trade Alerts - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

11 Best Micro-Cap Stocks to Invest in According to Analysts - Insider Monkey

Dec 04, 2025
pulisher
Dec 03, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $82.17 Average Target Price from Brokerages - Defense World

Dec 03, 2025
pulisher
Dec 02, 2025

Tectonic Therapeutic (TECX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

Tectonic Therapeutic to Participate in December Investor Conferences - The Manila Times

Dec 01, 2025
pulisher
Dec 01, 2025

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 01, 2025
pulisher
Dec 01, 2025

Tectonic Therapeutic (NASDAQ: TECX) to join Piper Sandler fireside chat, Evercore investor meetings in December - Stock Titan

Dec 01, 2025
pulisher
Nov 27, 2025

Can Tectonic Therapeutic Inc. stock deliver strong Q4 earnings2025 AllTime Highs & Weekly Setup with High ROI Potential - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

Its Stock Has Paid Off Big Time For Tectonic Therapeutic Inc - Setenews

Nov 27, 2025
pulisher
Nov 22, 2025

Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Nov 22, 2025
pulisher
Nov 20, 2025

Will Tectonic Therapeutic Inc. stock deliver long term returnsJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will Tectonic Therapeutic Inc. stock keep outperforming rivalsJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Tectonic Therapeutic Inc. forming a reversal patternMarket Trend Report & Reliable Intraday Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What is the fair value of Tectonic Therapeutic Inc. stock nowWeekly Stock Recap & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Tools to monitor Tectonic Therapeutic Inc. recovery probabilityTrade Exit Report & Weekly Stock Breakout Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Is Tectonic Therapeutic Inc. meeting your algorithmic filter criteriaEarnings Risk Summary & Safe Entry Zone Tips - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

How high can Tectonic Therapeutic Inc. stock goJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Tectonic: Strong Buy On Positive Phase 1b TX45 Data And 2026 Inflection Point (TECX) - Seeking Alpha

Nov 17, 2025
pulisher
Nov 15, 2025

Price action breakdown for Tectonic Therapeutic Inc.Portfolio Risk Summary & Verified Short-Term Trading Plans - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Tectonic Therapeutic Inc Stock Analysis and ForecastStock Market Trends & These 3 Stocks Could Change Your Portfolio - earlytimes.in

Nov 15, 2025
pulisher
Nov 15, 2025

What data driven models say about Tectonic Therapeutic Inc.’s futureShare Buyback & Daily Volume Surge Trade Alerts - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

What recovery options are there for Tectonic Therapeutic Inc.2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Will Tectonic Therapeutic Inc. stock outperform value stocks2025 Dividend Review & Free Low Drawdown Momentum Trade Ideas - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 13, 2025

How to track smart money flows in Tectonic Therapeutic Inc.July 2025 Sector Moves & Breakout Confirmation Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Can Tectonic Therapeutic Inc. stock sustain market leadership2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com

Nov 13, 2025

Tectonic Therapeutic Inc Stock (TECX) Financials Data

There is no financial data for Tectonic Therapeutic Inc (TECX). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Cap:     |  Volume (24h):